Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Enrolled in Pafolacianine Sodium Trial for Lung Cancer Lesions

americanpharmaceuticalreviewJuly 20, 2020

Tag: pafolacianine sodium , lung cancer , On Target

PharmaSources Customer Service